濮阳东方医院治疗早泄评价很高濮阳东方医院男科割包皮收费合理,濮阳东方男科好不好啊,濮阳东方男科医院评价比较好,濮阳东方医院男科割包皮手术费用,濮阳东方医院治疗早泄价格合理,濮阳东方医院看男科病非常靠谱,濮阳东方医院治疗阳痿口碑好很放心

BEIJING, Oct. 21 (Xinhua) -- China on Friday urged the European Union (EU) to recognize its full-market economy status at an early date and properly settle trade disputes amid the tumbling world economy."China hopes Belgium will exert its influence to push for an early recognizing of China's full-market economy status and remind the EU to be cautious on and restrain from using trade remedy measures," Vice Premier Wang Qishan told visiting Crown Prince Philippe of Belgium.Wang urged the 27-member bloc, also China's largest trade partner, to properly settle trade disputes with China during the talks at Diaoyutai State Guesthouse in downtown Beijing.Chinese Vice Premier Wang Qishan (R) shakes hands with Belgian Crown Prince Philippe in Beijing, capital of China, Oct. 21, 2011."China has contributed a lot to the world economy by recording a 9.4 percent growth in the first three quarters of this year while adjusting its economic structure and managing inflation expectations," Wang said.Prince Philippe, accompanied by a 450-member business delegation, is here to tap the Chinese market and seek investments from China, the world's top holder of foreign exchange reserves.During the 10-day trip, the delegation will visit the Chinese cities of Tianjin, Guangzhou, Shenzhen, Shanghai and Chongqing and is expected to sign about 40 contracts.Wang said China will expand two-way investment with Belgium, and enhance support to the two states' small and medium-sized enterprises via the China-Belgium direct equity investment fund.China-Belgium trade has continued to surge since the two states forged diplomatic ties in 1971, when the bilateral trade volume was only 20 million U.S. dollars, much less than the 22.1 billion U.S. dollar record in 2010."We could expand cooperation in two-way investment, trade, finance, chemical industry, environmental protection, logistics, and green economy," Wang said.

WASHINGTON, Dec. 7 (Xinhua) -- The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida.Their report, published on-line Wednesday in Gynecologic Oncology, suggests that this combination, ixabepilone and sunitinib, might offer a much needed treatment option for women with advanced ovarian cancer.Neither drug is approved for use in ovarian cancer. Ixabepilone is a chemotherapy drug that, like other taxane drugs, targets the microtubules and stops dividing cells from forming a spindle. It has been approved for use in metastatic breast cancer. Sunitinib, approved for use in kidney cancer, belongs to a class of tyrosine kinase inhibitors that stops growth signals from reaching inside cancer cells.When caught at late stages, ovarian cancer is often fatal because it progressively stops responding to the chemotherapy drugs used to treat it."Women die from ovarian cancer because their tumors become resistant to chemotherapy, so a drug that might be able to reduce that resistance -- which may be what this combination of agents is doing -- would be a boon to treatment of this difficult cancer," says study coauthor Gerardo Colon-Otero.The finding also highlights the importance of the role of a molecule, RhoB, that the researchers say is activated by the drug duo. It might be a potential biomarker that may help identify patients who might benefit from such combination therapy, the researchers say.

WASHINGTON, Dec. 16 (Xinhua) -- The U.S. International Trade Commission (USITC) Friday launched a probe into certain products from China after several U.S. companies alleged their patents were infringed.The products in question include televisions and Blu-ray players produced by Haier Group of China and Vizio Inc. under Taiwan-based Amtran Technology Company and sold in the U.S. market, the USITC said.` Five U.S. technology companies filed a complaint with USITC last month, saying those products violated Section 337 of the Tariff Act of 1930 by infringing their patents.Meanwhile, they requested the USITC issue an exclusion order and a cease and desist order against those products from China.The trade panel is scheduled to set a target date for completing the investigation within 45 days after institution of the probe. If the complaint is approved, the agency will ban importation of those products.The U.S. move came at a time when protectionism is making a comeback in the United States amid sluggish economic recovery.It is widely believed that such actions would only hurt U.S.- China trade relations that are increasingly critical to global economic recovery.

PARIS, Dec. 23 (Xinhua) -- French health authorities on Friday urged 30,000 women to remove the local-made breast implant, pledging that relevant expenses would be covered by the state.The health ministry said in a statement that they spot "no increased risk of cancer currently in women wearing the PIP (Poly Implant Prothese) brand compared with other implants.""However, well-established risks associated with these prostheses are rupture and irritant gel may lead to inflammatory reactions, making it difficult to explant," the statement added.French Health Minister Xavier Bertrand advised French women who have the PIP implants to get them taken out "as a preventive measure but not of an urgent nature." The removal of the implant will be at the state's expense.The recommendation came after eight cases, mainly breast cancer, were reported recently among women with PIP implants.The involved implant was produced by the French company PIP, once the world's third-largest producer of silicone implants who sold its products to tens of thousands of women in more than 65 countries, mainly in South America and western Europe.

HANOI, Oct. 7 (Xinhua) -- Vietnam in cooperation with the United Nations Development Program (UNDP) and the Food and Agriculture Organization (FAO) organized a workshop here on Friday to finalize implementations in Phase 2 of the UN-Vietnam Joint Program to fight against Highly Pathogenic Avian Influenza (HPAI) during 2007-2011.The workshop is not only to review the achievements but also from that, Vietnam hopes to receive more supports from the UN agencies, said Bui Ba Bong, Vietnamese vice minister of Agriculture and Rural Development.According to the report, so far, Vietnam's project on prevention of HPAI has basically achieved the targets in terms of making plans, policies and strategies for the veterinary sector, assessing the impacts of destruction of poultry to the environment, controlling pandemic, and supporting vaccine inoculation, quarantine and control of the infected animals, said Bong.Vietnam showed great efforts in responding and preventing H5N1 pandemic during its occurrence in 2005-2006, evaluated UN agencies.In Phase 2, Vietnam achieved positive results in controlling and reducing the impacts of the pandemic, and promoting bio- security in livestock breeding. Therefore, UN pledged to continue assisting Vietnam in the future.The UN-Vietnam joint program to fight HPAI was designed to meet the needs of emergency assistance to control the avian and human influenza.Total fund of the program is 25 million U.S. dollars, of which over 18 million U.S. dollars was approved for Phase 2.